Cargando…

PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer

BACKGROUND: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphate-4 (PFKFB4) is a key factor that plays an important role in tumorigenesis. However, its role in triple-negative breast cancer (TNBC) progression needs to be further validated. We investigated whether PFKFB4 is directly involved in the onco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yu-Chen, Yang, Hang, Shan, Hong-Bo, Su, Hui-Fang, Jiang, Wen-Qi, Shi, Yan-Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211511/ https://www.ncbi.nlm.nih.gov/pubmed/34211613 http://dx.doi.org/10.1155/2021/8824589

Ejemplares similares

Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
por: Li, Jun, et al.
Publicado: (2022)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

Overexpression of CASC19 indicates poor prognosis and facilitates proliferation, migration and invasion in colorectal cancer
por: Zhao, Jiang, et al.
Publicado: (2019)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma
por: Xia, Xiu-Liang, et al.
Publicado: (2018)

ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer
por: Cai, Yu-Chen, et al.
Publicado: (2020)

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
por: Yao, Ling, et al.
Publicado: (2019)

PFKFB4 as a promising biomarker to predict a poor prognosis in patients with gastric cancer
por: Wang, Fang, et al.
Publicado: (2021)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
por: Trojan, Sonia E., et al.
Publicado: (2019)

PFKFB3 promotes proliferation, migration and angiogenesis in nasopharyngeal carcinoma
por: Gu, Miao, et al.
Publicado: (2017)

Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer
por: Gao, Bo, et al.
Publicado: (2021)

High expression of CD47 in triple negative breast cancer is associated with epithelial-mesenchymal transition and poor prognosis
por: Yuan, Jingping, et al.
Publicado: (2019)

circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis
por: Yu, Jinling, et al.
Publicado: (2020)

Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial–mesenchymal transition in gastric cancer
por: He, Xiaobo, et al.
Publicado: (2022)

A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression
por: Lei, Lan, et al.
Publicado: (2021)

Overexpression of SYF2 promotes cell proliferation and correlates with poor prognosis in human breast cancer
por: Shi, Feng, et al.
Publicado: (2017)

Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma
por: Gu, Xue, et al.
Publicado: (2023)

PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells
por: Bostanabad, Saber Yari, et al.
Publicado: (2021)

P880: OVEREXPRESSION OF PFKFB4 PROMOTES ADAPTATION TO HYPOXIC MICROENVIRONMENT IN MULTIPLE MYELOMA
por: Yang, J., et al.
Publicado: (2022)

Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism
por: Zhou, Yong, et al.
Publicado: (2022)

Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
por: Zhou, Yujuan, et al.
Publicado: (2016)

PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
por: Dou, Qianhui, et al.
Publicado: (2022)

Long non-coding RNA MSC-AS1 facilitates the proliferation and glycolysis of gastric cancer cells by regulating PFKFB3 expression
por: Jin, Xianzhen, et al.
Publicado: (2021)

Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer
por: Gao, Xunfeng, et al.
Publicado: (2017)

Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer
por: Jiang, Tao, et al.
Publicado: (2017)

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2018)

Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)

Overexpression of MiR-146a-5p Upregulates lncRNA HOTAIR in Triple-Negative Breast Cancer Cells and Predicts Poor Prognosis
por: Liang, Hongguang, et al.
Publicado: (2019)

Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
por: Ferrari, Nicola, et al.
Publicado: (2014)

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer
por: Luo, Rong-Zhen, et al.
Publicado: (2013)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
por: Zhao, Zi-Ming, et al.
Publicado: (2019)

MAT2B expression correlates with poor prognosis in triple-negative breast cancer
por: Xu, Jin, et al.
Publicado: (2019)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
por: Kim, So-Woon, et al.
Publicado: (2021)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
por: Bissanum, Rassanee, et al.
Publicado: (2022)

Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins
por: Ying, Hanning, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4d456tljkprqrlkitpea0c06ka